scispace - formally typeset
N

Nora D. Volkow

Researcher at National Institute on Drug Abuse

Publications -  1038
Citations -  121498

Nora D. Volkow is an academic researcher from National Institute on Drug Abuse. The author has contributed to research in topics: Dopamine & Addiction. The author has an hindex of 165, co-authored 958 publications receiving 107463 citations. Previous affiliations of Nora D. Volkow include National Institutes of Health & North Shore University Hospital.

Papers
More filters
Journal Article

PET scanning of iodine-124-3F9 as an approach to tumor dosimetry during treatment planning for radioimmunotherapy in a child with neuroblastoma.

TL;DR: Positron emission tomography of 124I-labeled antibodies can be used to measure cumulated activity or residence time in tumor for more accurate estimates of radiation absorbed tumor dose from radioiodinated antibodies and can help guide management decisions in patients who are candidates for radioimmunotherapy.
Journal ArticleDOI

Neuroimaging for drug addiction and related behaviors

TL;DR: This review focuses on studies employing positron emission tomography, functional magnetic resonance imaging, and electroencephalography to investigate these behaviors in drug-addicted human populations and discusses how these techniques have uniquely contributed to a deeper understanding of addictive behaviors.
Journal ArticleDOI

Enhanced resting activity of the oral somatosensory cortex in obese subjects

TL;DR: Obese subjects have significantly higher metabolic activity in the bilateral parietal somatosensory cortex in the regions where sensation to the mouth, lips and tongue are located, which could make them more sensitive to the rewarding properties of food related to palatability.
Journal ArticleDOI

Decreased cerebral response to inhibitory neurotransmission in alcoholics.

TL;DR: The alcoholic subjects had a blunted response to lorazepam that was specific to certain brain regions that was seen in the alcoholic subjects, suggesting that the cerebellum may contribute to the decreased sensitivity to lOrazepham.